TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 348 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2019. The put-call ratio across all filers is 0.95 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $5,465,000 | -43.7% | 333,617 | -42.1% | 0.02% | -43.6% |
| Q2 2021 | $9,703,000 | -9.9% | 576,551 | -2.3% | 0.04% | -15.2% |
| Q1 2021 | $10,775,000 | +16.8% | 590,074 | +16.5% | 0.05% | +7.0% |
| Q4 2020 | $9,222,000 | -46.5% | 506,704 | -47.6% | 0.04% | -51.1% |
| Q3 2020 | $17,236,000 | -13.1% | 966,167 | -12.7% | 0.09% | -24.1% |
| Q2 2020 | $19,842,000 | +6.1% | 1,106,642 | -10.2% | 0.12% | -12.1% |
| Q1 2020 | $18,705,000 | -19.2% | 1,232,212 | +5.0% | 0.13% | +0.8% |
| Q4 2019 | $23,145,000 | +9.1% | 1,173,087 | -4.9% | 0.13% | +4.8% |
| Q3 2019 | $21,224,000 | -5.8% | 1,233,944 | -3.1% | 0.12% | -7.4% |
| Q2 2019 | $22,536,000 | +53.3% | 1,273,211 | +76.4% | 0.14% | +48.4% |
| Q1 2019 | $14,702,000 | – | 721,739 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Glenview Capital Management | 16,104,222 | $294,063,000 | 4.98% |
| GMT CAPITAL CORP | 2,468,695 | $45,078,000 | 3.31% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,065,756 | $19,461,000 | 3.13% |
| Blackcrane Capital, LLC | 14,571 | $1,723,000 | 2.72% |
| BFAM Partners (Cayman) Ltd | 328,690 | $6,002,000 | 2.36% |
| Paulson & Co. | 4,727,415 | $86,323,000 | 1.98% |
| Mondrian Investment Partners LTD | 3,510,404 | $59,677,000 | 1.28% |
| Lumbard & Kellner, LLC | 135,550 | $2,264,000 | 0.80% |
| DAVIDSON INVESTMENT ADVISORS | 500,203 | $9,134,000 | 0.78% |
| TFG Asset Management GP Ltd | 589,390 | $10,762,000 | 0.77% |